NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
NNVC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-0.93%291.401.4%$865.23m
AMGNAmgen, Inc.
0.28%221.311.3%$495.03m
CELGCelgene Corp.
0.39%110.001.3%$448.97m
GILDGilead Sciences, Inc.
-0.50%64.321.0%$384.61m
ILMNIllumina, Inc.
0.25%295.733.5%$305.32m
VRTXVertex Pharmaceuticals, Inc.
0.97%203.861.9%$290.09m
REGNRegeneron Pharmaceuticals, Inc.
1.20%348.412.6%$262.04m
EXASEXACT Sciences Corp.
-0.77%79.9124.0%$196.13m
ALXNAlexion Pharmaceuticals, Inc.
0.39%109.442.0%$190.16m
SGENSeattle Genetics, Inc.
2.16%110.646.1%$126.52m
BMRNBioMarin Pharmaceutical, Inc.
0.73%75.884.3%$110.72m
SRPTSarepta Therapeutics, Inc.
5.46%99.9514.6%$106.88m
AAgilent Technologies, Inc.
0.26%77.051.6%$100.02m
MRTXMirati Therapeutics, Inc.
1.12%104.332.3%$89.09m
NBIXNeurocrine Biosciences, Inc.
0.50%111.405.0%$84.24m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.